Does a 36-year-old woman with a Beighton score of 5 and flat feet meet criteria for hypermobile Ehlers-Danlos syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypermobile Ehlers-Danlos Syndrome Assessment

A 36-year-old woman with a Beighton score of 5 and flat feet meets the first criterion for hypermobile EDS (generalized joint hypermobility), but requires assessment of additional musculoskeletal/systemic features and exclusion of alternative diagnoses before confirming the diagnosis. 1

Diagnostic Framework for hEDS

The American College of Medical Genetics and Genomics requires three mandatory criteria to be fulfilled for hypermobile EDS diagnosis: 1

Criterion 1: Generalized Joint Hypermobility (✓ MET)

  • Your patient meets this criterion with a Beighton score of 5/9, which is the required threshold for adults under 50 years old 1
  • The Beighton scale includes: passive fifth finger dorsiflexion >90°, thumb apposition to forearm, elbow hyperextension >10°, knee hyperextension >10°, and ability to place palms flat on floor with knees extended 1

Criterion 2: Musculoskeletal and Systemic Manifestations (REQUIRES ASSESSMENT)

You must now evaluate for Feature A (required) plus Feature B or C: 1

Feature A - Musculoskeletal complications (≥1 required):

  • Recurrent joint dislocations or subluxations affecting multiple joints 1
  • Chronic joint and limb pain that is severely disabling 1
  • Chronic, widespread pain for ≥3 months 1

Feature B - Additional systemic manifestations (≥3 required):

  • Soft, velvety skin texture 1
  • Easy bruising without significant trauma 1
  • Functional bowel disorders (IBS, functional gastritis) 1
  • Orthostatic intolerance or POTS (heart rate increase ≥30 bpm within 10 minutes of standing) 1
  • High, narrow palate with dental crowding 1
  • Arachnodactyly, pectus deformity, or other skeletal features 1

Feature C - Family history:

  • First-degree relative meeting hEDS criteria 1

Note on flat feet: While pes planus (flat feet) represents a musculoskeletal finding consistent with connective tissue laxity, it alone does not fulfill the specific criteria outlined above. 2

Criterion 3: Exclusion of Alternative Diagnoses (CRITICAL STEP)

This criterion is frequently overlooked but essential. 3 Recent evidence demonstrates that 26.4% of patients initially meeting hEDS criteria actually had alternative or additional diagnoses identified through genetic testing that required distinct management strategies. 3

Mandatory exclusion workup includes:

  • Genetic testing to exclude other EDS subtypes (particularly vascular EDS with COL3A1 testing if there are any vascular features, thin translucent skin, or characteristic facial features) 1
  • Evaluation for other heritable connective tissue disorders (Marfan syndrome, Loeys-Dietz syndrome) 3
  • Assessment for inflammatory diseases, monogenic syndromes, and chromosomal abnormalities that can present with joint hypermobility 3

Critical Clinical Pitfalls

Do not assume hEDS diagnosis based solely on Beighton score. 3 A Beighton score of 5 indicates generalized joint hypermobility but does not distinguish between:

  • Hypermobile EDS (requires all 3 criteria) 1
  • Hypermobility spectrum disorders (symptomatic hypermobility not meeting full hEDS criteria) 4
  • Benign joint hypermobility (asymptomatic) 5

The diagnostic odyssey is common in these patients. 5 Referral to genetics, physical medicine and rehabilitation, or rheumatology is recommended to complete the comprehensive evaluation and prevent complications. 5

Associated Conditions to Screen For

If hEDS is confirmed, evaluate for common comorbidities that affect management: 1, 6

  • Postural orthostatic tachycardia syndrome (POTS) - affects up to 37.5% of hEDS patients 2
  • Functional gastrointestinal disorders - affect up to 98% of patients 1, 2
  • Mast cell activation syndrome 6
  • Aortic root dilation (occurs in 25-33% of classic and hypermobile EDS) - requires echocardiography 1, 2

Management Approach if Diagnosis Confirmed

Low-resistance exercise is the cornerstone of management to improve joint stability through symmetric muscle strengthening, though physical therapy for myofascial release should precede exercise programs. 2 Multidisciplinary pain management is often required for chronic pain syndromes. 1

References

Related Questions

Is hypermobile Ehlers-Danlos Syndrome (hEDS) associated with thyroid conditions?
What laboratory tests are recommended for a patient with hypermobile Ehlers-Danlos Syndrome (hEDS)?
How does Hypermobile Ehlers-Danlos Syndrome (hEDS) affect adipose tissue?
Should I be concerned if I experience increased body soreness, knots in my back, and shoulder subluxations weeks after receiving iron infusions for hypermobile Ehlers-Danlos Syndrome (hEDS)?
What are the likely causes of persistent knee pain in someone with hypermobile Ehlers-Danlos syndrome (hEDS) after taking a stair step?
Can clonazepam cause an elevated gamma‑glutamyl transferase?
What is the recommended management of an uncomplicated cellulitis located near a joint in a healthy adult?
What is the most likely diagnosis and recommended work‑up for a patient with a livedo‑type rash, skin tenderness, fatigue and brain fog, who has normal partial thromboplastin time, normal activated partial thromboplastin time, normal erythrocyte sedimentation rate and mildly elevated C‑reactive protein?
At day 15 after femoral cardiac catheterization, what activities can an adult patient with a groin hematoma (first noted day 7, no pseudoaneurysm) safely resume while on antiplatelet therapy?
Do herbal extracts for lymphatic drainage reliably improve lymphatic flow or reduce edema?
What is the next step in evaluating an 80‑year‑old patient with markedly elevated alkaline phosphatase, moderately elevated transaminases, and a normal right upper quadrant ultrasound?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.